Metraipolis › archive › dc_b77e96a1663d

Development and characterization of a model of mucopolysaccharidosis type IVA for evaluating therapies targeting bone disease — Europe PMC PMID:41783940

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41783940
DOI: 10.1242/dmm.052540
License (as archived): solo-consultazione
Archived: 2026-11-06T08:22:14.219Z
SHA-256 of the archived text: dd932909f57ae1e0f2b1abc37ff3a2654bf00d131a57c16b1e1e15a4e9a61906
Stable URL of this page: https://metraipolis.com/documento/dc_b77e96a1663d

How to cite

Development and characterization of a model of mucopolysaccharidosis type IVA for evaluating therapies targeting bone disease — Europe PMC PMID:41783940 — Europe PMC (en), https://europepmc.org/article/MED/41783940 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b77e96a1663d (Metraipolis archive dc_b77e96a1663d, sha256 dd932909f57ae1e0f2b1abc37ff3a2654bf00d131a57c16b1e1e15a4e9a61906)

BibTeX

@misc{dcb77e96a1663d,
  title = {Development and characterization of a model of mucopolysaccharidosis type IVA for evaluating therapies targeting bone disease — Europe PMC PMID:41783940},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41783940},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b77e96a1663d; sha256 dd932909f57ae1e0f2b1abc37ff3a2654bf00d131a57c16b1e1e15a4e9a61906},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41783940. Agents can read the archived copy with the MCP tool read_document.